INPP4B and prostate cancer: Together, our data strongly suggest that INPP4B mRNA expression in human prostate cancer responds to castration, thereby cautioning that androgen ablation therapies might contribute to cancer progression, possibly by reducing INPP4B expression and activation of signaling pathways normally suppressed by INPP4B.